Most people who want to drink less never reach for a prescription. Not because the option doesn't exist — but because few people know it does. Naltrexone for alcohol moderation has been studied in clinical trials for over three decades. The Sinclair Method, one specific dosing approach, has drawn growing attention from researchers and clinicians who want options that go beyond all-or-nothing thinking.
This guide covers what the research says, how both daily and targeted naltrexone dosing work, and what questions to bring to your provider if you're exploring this path.
Important safety note: If you are experiencing severe alcohol dependence — including withdrawal symptoms such as tremors, sweating, or anxiety when you stop drinking — please seek in-person medical supervision before making any changes. For immediate support, contact the SAMHSA National Helpline: 1-800-662-4357 (free, confidential, 24/7).
What Is Naltrexone and How Does It Work for Alcohol Use?
Naltrexone is an FDA-approved medication that works by blocking opioid receptors in the brain — receptors that alcohol activates to produce feelings of reward and relaxation. When those receptors are blocked, the pleasurable reinforcement that makes drinking feel compelling is significantly reduced. Over time, research suggests this can lower cravings and reduce how much a person drinks. Naltrexone is non-addictive and does not cause sedation or euphoria.
Naltrexone was first approved by the FDA for alcohol use disorder (AUD) in oral tablet form in 1994, making it one of only three medications currently approved for this indication in the United States. According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), it reduces alcohol cravings and consumption by interfering with the brain's reward cycle — without requiring prior detoxification in most cases.1
The scale of alcohol use disorder in the U.S. makes this relevant to a large population. According to the 2024 National Survey on Drug Use and Health (NSDUH), 27.1 million adults ages 18 and older — approximately 10.3% of U.S. adults — met the criteria for AUD in the past year.2
What Is the Sinclair Method (TSM)?
The Sinclair Method is a targeted naltrexone protocol in which the medication is taken one to two hours before drinking — not every day. The goal is not immediate abstinence. Instead, it aims to gradually reduce alcohol consumption over weeks and months by using a process called pharmacological extinction.
Finnish researcher Dr. John D. Sinclair spent decades studying how conditioned behaviors are extinguished in the brain. His core insight: if the brain's reward signal is blocked every time a person drinks, the neural pathways that drive compulsive drinking are weakened through repetition. The brain essentially learns that alcohol is no longer rewarding.
In a 2001 paper published in Alcohol and Alcoholism (Oxford Academic), Sinclair reviewed evidence from multiple double-blind, placebo-controlled trials across five countries. His analysis found that targeted naltrexone dosing was consistently effective when the medication was taken in conjunction with drinking — and less effective when administered during periods of abstinence, which he argued was consistent with the extinction mechanism.3
A 2001 randomized controlled trial by Heinälä et al., published in the Journal of Clinical Psychopharmacology, examined targeted naltrexone use without prior detoxification. Participants who used naltrexone in targeted fashion showed significant reductions in drinking over the course of the study compared to placebo, with results strengthening over time — consistent with an extinction model in which benefits accumulate across drinking occasions.3
What makes TSM different from daily naltrexone dosing:
| Approach | Dosing schedule | Goal |
|---|---|---|
| Daily naltrexone | Every day, regardless of drinking | Reduce overall craving; support abstinence |
| Sinclair Method (TSM) | Only before drinking | Pharmacological extinction; reduce drinking over time |
| Extended-release injectable | Monthly injection | Compliance; abstinence support |
Both daily oral naltrexone and the Sinclair Method use the same FDA-approved medication — the difference is timing and therapeutic intent. Most published guidelines support daily dosing for abstinence goals. The Sinclair Method is more often discussed in the context of moderation as an outcome.
What Does the Clinical Evidence Show?
Naltrexone has a meaningful evidence base. A meta-analysis published in the International Journal of Neuropsychopharmacology (Oxford Academic), reviewing randomized controlled trials, found that naltrexone was significantly more effective than placebo in reducing drinking days and the likelihood of relapse to heavy drinking.4
Separately, NIAAA-supported research has found that patients receiving naltrexone — alone or combined with behavioral counseling — demonstrated meaningfully better drinking outcomes after 16 weeks of outpatient treatment compared to placebo controls.1 The NIAAA notes that naltrexone was significantly better than placebo for supporting abstinence and extending time to the first heavy drinking day.
A few important caveats the research consistently surfaces:
- Adherence matters. Naltrexone's effects depend on consistently taking it as prescribed. For the Sinclair Method specifically, taking the medication before every drinking occasion — not skipping doses — is central to the extinction process.
- Individual response varies. A genetic variant in the opioid receptor gene (OPRM1) may influence how strongly a person responds to naltrexone. Some research suggests carriers of the Asn40Asp variant (the "A118G" polymorphism) may have stronger responses, though this is not yet standard clinical practice.
- Motivation matters too. Naltrexone is not a standalone fix. Most trials pair it with some form of behavioral or medical support.
- It is not appropriate for everyone. People who use opioids, are in opioid withdrawal, or have significant liver impairment should not take naltrexone. A provider evaluation is essential before starting.
Daily Dosing vs. the Sinclair Method: Which Approach Is Right for You?
The right approach depends on your goal, your drinking pattern, and what your provider recommends.
Daily naltrexone is the approach most commonly used in clinical settings and the one supported by the majority of published treatment guidelines, including SAMHSA and NIAAA. It is often prescribed when the goal is full abstinence or when a person is already motivated to stop drinking entirely.
The Sinclair Method tends to attract people whose goal is moderation rather than abstinence — people who want to keep drinking socially but break the compulsive or escalating pattern. It also appeals to those who have not responded to abstinence-focused programs or who are not ready to stop entirely.
A few honest points worth knowing:
- The Sinclair Method is not universally endorsed by U.S. clinical guidelines. SAMHSA and NIAAA guidelines describe naltrexone primarily in the context of daily dosing combined with behavioral support. Clinicians who prescribe TSM do so within the FDA-approved label for naltrexone, but the specific TSM protocol is not itself guideline-endorsed in the way daily dosing is.
- Extinction takes time. Most published data suggest the process unfolds over three to six months of consistent use. There is no immediate effect; the shift in craving and consumption builds across multiple drinking occasions.
- Some people reach full abstinence through TSM. Sinclair's 2001 analysis cited a 78% rate of achieving extinction outcomes (defined as reaching low-risk drinking levels or abstinence) across clinical trials. These figures come from controlled settings and may not reflect every real-world context.
The bottom line: both approaches use the same FDA-approved, non-addictive medication. The difference is strategy. A licensed provider can help you decide which approach fits your situation.
What to Expect from Physician-Directed Naltrexone
If a provider determines naltrexone is appropriate for you, here is what the general process looks like:
- Intake and evaluation. Your provider reviews your drinking history, current health, liver function, and any opioid use (naltrexone is contraindicated with active opioid use and can precipitate withdrawal). Bloodwork is often requested.
- Prescription and dispensing. Naltrexone is an FDA-approved oral tablet dispensed by a licensed pharmacy. It is not compounded. Standard oral dosing is 50 mg daily (or before drinking, for TSM).
- Ongoing check-ins. Providers typically schedule follow-up appointments to assess response, adjust if needed, and monitor liver enzymes, especially in the early months.
- Behavioral support. Most evidence suggests naltrexone works best alongside some form of counseling, peer support, or structured behavioral guidance — though some patients use medication management as a standalone approach.
Physician-directed naltrexone is available through Nuvari's Reclaim Protocol.
Frequently Asked Questions
Does naltrexone make you sick if you drink alcohol?
Naltrexone does not cause a disulfiram-like reaction (the severe nausea and flushing that disulfiram causes when combined with alcohol). It does not make you ill for drinking. Its mechanism is different: it blocks the reward signal rather than creating an aversive reaction. Some people report reduced enjoyment of drinking, which is the intended effect. Nausea is a possible side effect of naltrexone itself — particularly when starting the medication — but it is not caused by the combination with alcohol.5
Can naltrexone be used long-term?
FDA prescribing information does not set a defined time limit for oral naltrexone use. Long-term use has been studied and is considered by many clinicians. Liver enzyme monitoring is typically recommended, particularly in patients with pre-existing liver conditions, as naltrexone carries a warning for hepatotoxicity at very high doses. Your provider will determine an appropriate duration and monitoring plan for your situation.5
Is naltrexone only for people with severe alcohol use disorder?
No. Naltrexone is FDA-approved for the full spectrum of alcohol use disorder and has been studied in populations ranging from heavy drinkers to those meeting criteria for severe AUD. Some research specifically examines its use in people who are not seeking full abstinence. Whether it is appropriate for a given individual is a clinical determination — not one based on how severe the problem is perceived to be.
How long does the Sinclair Method take to work?
Based on published research, pharmacological extinction through TSM typically unfolds over several months of consistent use. Sinclair's clinical review described an extinction process building over weeks to months of continued drinking with naltrexone on board. Most participants in clinical trials showed meaningful reductions in drinking within the first 12 weeks, with effects often strengthening at the 6-month mark.3
Do I need to stop drinking before starting naltrexone?
For oral naltrexone, detoxification prior to starting is generally not required — unlike some other AUD medications. However, a full clinical evaluation is necessary. Your provider will review your health history, current medications, and drinking pattern to determine whether naltrexone is appropriate and when to start. If you are physically dependent on alcohol (meaning you experience withdrawal symptoms), medical supervision during any reduction is important for your safety.
The Bottom Line
Naltrexone is a well-studied, FDA-approved option for people who want to change their relationship with alcohol. Both daily dosing and the Sinclair Method have evidence behind them — and meaningful differences in how they're used and what they're designed to achieve. Neither is a replacement for a provider relationship. Both deserve to be more widely known.
If you're exploring what physician-directed support looks like, talking to a licensed clinician is the right first step.
If you or someone you know needs immediate support with alcohol use, contact the SAMHSA National Helpline: 1-800-662-4357 — free, confidential, available 24 hours a day, 7 days a week.
Sources
- National Institute on Alcohol Abuse and Alcoholism (NIAAA). "Naltrexone Treatment." https://www.niaaa.nih.gov/health-professionals-communities/native-air/treatment-alcohol-use-disorder/naltrexone-treatment
- National Institute on Alcohol Abuse and Alcoholism (NIAAA). "Alcohol Use Disorder (AUD) in the United States: Age Groups and Demographic Characteristics." 2024 NSDUH data. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-topics/alcohol-facts-and-statistics/alcohol-use-disorder-aud-united-states-age-groups-and-demographic-characteristics
- Sinclair JD. "Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism." Alcohol and Alcoholism. 2001;36(1):2–10. https://academic.oup.com/alcalc/article/36/1/2/137995
- Srisurapanont M, Jarusuraisin N. "Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials." International Journal of Neuropsychopharmacology. 2005;8(2):267–280. https://academic.oup.com/ijnp/article/8/2/267/755449
- U.S. Food and Drug Administration. Naltrexone hydrochloride tablet, film coated — Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06ff2d5a-e62b-4fa4-bbdb-01938535bc65